Reduce Patient Burden and Improve Outcomes with Real World Data
May 25, 2022
Today, the multiple disparate touchpoints required for clinical research are burdensome for patients, sites, and sponsors. Patient engagement, recruitment, and surveillance for trials are crucial to unlocking these challenges and expanding research access. In this discussion, Medable, Datavant, Seqster, and Abbvie will illustrate examples of successful application of novel technologies within clinical trials to enhance the patient journey and improve time to treatment.
Join speakers from Medable, Datavant, Seqster, and Abbvie as they share:
- A secure, patient-centric, and real-time data connectivity approach to clinical trials
- Successful clinical and commercial applications of Datavant, Seqster, and Medable technologies
- Solutions that transform each step of the patient journey from pre-clinical to post-clinical experience
- How to improve patient engagement, recruitment, and longitudinal surveillance
Vice President of Life Sciences
Tyler Pugsley, Medable’s Vice President of Life Sciences has almost a decade of experience partnering with pharmaceutical sponsors and CROs to advise and develop innovative clinical trial technologies. An evangelist in the Medable mission of bringing effective therapies to patients faster, Tyler consistently pushes the boundaries of what is considered possible in clinical trials.
CEO & Co-Founder
Ardy Arianpour is CEO & Co-Founder of Seqster, the leading patient-centric SaaS healthcare technology company that enables organizations to drive efficient healthcare via comprehensive medical records (EHR), individual genomic profiles (DNA), and personal health device data. For the first time, users create their own matched, longitudinal health data profile across all of their US-based healthcare data sources through person-centric interoperability.
Business Development, Clinical Trials
Devin leads strategy and business development for clinical trial solutions at Datavant, where he's helped to launch trial tokenization, enabling sponsors to link real-world data with clinical trials. Devin previously led real-world evidence solutions for the oncology data analytics company Syapse, where he worked with life sciences partners to build synthetic control arms and innovativeoutcomes research data products.
Christopher P. Boone, PhD, FACHE, FHIMSS
Vice President, Global Head of HEOR
Christopher Boone, PhD has a career-long history as a dynamic, innovative thought leader and a public voice on the power of real-world evidence, health informatics, and big data analytics and its ability to radically transform the global health care system into a learning health system.
Chris currently serves as the Vice President, Global Head of Health Economics and Outcomes Research at Abbvie. He is also an adjunct assistant professor of health administration at the New York University's Robert F. Wagner Graduate School of Public Service, an active board member of several influential organizations, and a co-founder of a few start-up companies. Prior to AbbVie, he served in two different roles at Pfizer: (1) the Vice President and Head of Global Medical Epidemiology and Big Data Analysis at Pfizer, and (2) the Vice President and Global Head of Real-World Data and Analytics.
Chris has been recognized as a 2020 Global Top 100 Innovator in Data & Analytics, a 2019 Top 100 Innovator in Data & Analytics, a 2018 Emerging Pharma Leader by Pharmaceutical Executive, and a 2017 Top 40 Under 40 Leader in Minority Health
by the National Minority Quality Forum (NMQF).
Cost: No cost!